Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1832588 (
PSS
)
2,979
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cl- efflux into various incubation media (
PSS
) was studied in pieces of rabbit aortae loaded with 36Cl. Replacement of HCO3-/CO2 by HEPES/O2 in the
PSS
increased the rate of Cl- efflux by a factor of 2.4. This effect was suppressed in Cl(-)-free
PSS
containing isethionate, propionate, or benzenesulfonate, but not in NO3(-)-
PSS
, or Br(-)-
PSS
. The stimulant effect of HCO3- withdrawal on Cl-efflux was reduced by 140 microM DIDS, but not by 1 mM furosemide. The Cl- efflux was temperature-dependent (
Q10
= 2.3-2.5), and it was not affected on depolarisation by high [K+]o. The [Cl-]i of rabbit aorta determined by uptake studies with 36Cl, decreased slightly (by 15%) below controls in
PSS
containing 140 microM DIDS, but drastically (from 32.6 to 13.5 mM, i.e. by 59%) in
PSS
containing 1 mM furosemide. Withdrawal of HCO3-/CO2 depolarized rabbit pulmonary artery in standard
PSS
and in Br(-)-
PSS
or NO3(-)-
PSS
, but not in benzenesulfonate-
PSS
. The pHi of rabbit aorta determined by the distribution of (14C)-DMO, increased in Cl(-)-free
PSS
containing isethionate or glucuronate. It is concluded that transport mechanisms play a major role in the distribution of Cl- in vascular smooth muscle, and that a membrane anion carrier operates in this tissue which can transport Cl- and HCO3- across the cell membrane. This mechanism seems to be involved in the regulation of pHi. However, the known high [Cl-]i of vascular smooth muscle is rather mediated by the furosemide-sensitive Na-K-Cl cotransport than by this anion carrier.
...
PMID:A chloride-bicarbonate exchanging anion carrier in vascular smooth muscle of the rabbit. 361 72